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FINAL EXAMINATION DURATION 
PHA213 – Pharmacology 2 
 
Reading Time: 10 minutes 
Writing Time: 180 minutes 
 
INSTRUCTIONS TO CANDIDATES 
 
The examination has 2 Sections (A and B): 
Section A contains Forty (40) Multiple Choice Questions.  Answer all questions in the Faculty/School 
supplied Multiple Choice Answer Sheet.  Total marks allocated: Twenty (20).  Suggested time allocation: 
One (1) hour. 
Section B contains Ten (10) Extended-Answer Questions.  Answer any Eight (8) of the 10 questions only 




You may begin writing from the commencement of the examination session.  The reading time 
indicated above is provided as a guide only. 
This is a CLOSED BOOK examination 
No calculators are permitted 
No handwritten notes are permitted 
No dictionaries are permitted 
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No additional printed material is permitted 
 
1 x 20 Page Book 
1 x Scrap Paper 
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Section A 
Multiple Choice Questions 
Total No of Marks for this section: 20 
 
The answers for this section must be written on the Faculty/School Multiple Choice 
Answer Sheet provided.  Please ensure that you write your name and student number 
on the Answer Sheet. 
Answer ALL (40) questions. 










End of Section A 
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Sections B  
Extended Answer Questions 
Total No. of Marks for these Sections: 80 
 
These sections must be answered in the Answer Booklets provided. 
Answer ANY EIGHT (8) of the TEN (10) questions only. 
 




The following agents are used in the treatment of osteoporosis.  Describe their 
mechanisms of action. 
a Reloxifene (3 marks) 
b Risedronate (3 marks) 










Question 2 (multiple topics) 
a Describe the mechanisms of action of the active ingredients in the above 
preparation and indicate what this preparation is used for (and also specify 
whether it is used as a reliever, controller or preventer). 
 (5 marks) 
b Explain how the use of a selective cyclooxygenase (COX) COX-1 inhibitor 
(such as low dose aspirin) can reduce the risk of acute myocardial infarction 
(AMI, commonly known as a heart attack), while a selective COX-2 inhibitor 
(such as rofecoxib) can increase the risk of AMI. 
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Question 3 (multiple topics) 
Describe the mechanism of action of the following antibacterial or cancer 
chemotherapeutic agents.  Identification of their therapeutic applications is not 
required.  For part b, explain the benefit of using this combined preparation. 
a Clarithromycin (2 marks) 
b Piperacillin with tazobactam (4 marks) 
c Trastuzumab (2 marks) 








a List the therapeutic uses of testosterone decanoate and the adverse health 
effects associated with the abuse of this agent (or structurally-related steroids 
such as nandrolone and stanozolol) in males, females and a child. 
 (5 marks) 
b Describe what is in the combined oral contraceptive pills and how these agents 
produce their effects on the female reproductive system to prevent pregnancy. 
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Question 5 (multiple topics) 
a Explain how the physicochemical properties of inhaled general anaesthetics 
can determine their speeds of onset of action and their potencies. 
 (5 marks) 
b Describe the mechanisms of action of the following therapeutic agents in the 
management of epilepsy and explain which of these agents is/are preferred for 
Myoclonic or Absence seizures. 
i. Sodium valproate 









Describe the mechanisms of action of the following antidiabetic agents in lowering 
the blood sugar level. 
a Acarbose (2 marks) 
b Gliclazide (3 marks) 
c Dapagliflozin (2 marks) 
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Question 7 (multiple topics) 
a Describe the mechanisms of action of the active ingredients in the above 
preparation and indicate what this preparation is used for. 
 (6 marks) 
b Describe the action and use of zolmitriptan in the management of migraine.  
What are the precautions when using this agent? 







a Describe the mechanism of action of benzodiazepines. 
 (4 marks) 
b Do all drugs which bind to the benzodiazepine binding sites produce the same 
effects?  Explain your answer and give examples. 
 (3 marks) 
c In comparison with older sedative-hypnotic drugs such as the barbiturates, 
what is the clinical consequence of benzodiazepine overdose?  Explain the 
difference with reference to the mechanisms of action of barbiturates and 
benzodiazepines. 
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a Describe the mechanisms of action of the following therapeutic agents used in 
the treatment of schizophrenia.  What are the advantages of using agent ii over 
agent i? 
i. Haloperidol 
ii. Aripiprazole (5 marks) 
b Strict dietary advice must be given to patients using phenelzine for depression.  
Explain what can happen, including the mechanism for its occurrence, if this 
advice is not followed. 







Question 10 (multiple topics) 
a Describe the mechanisms of action of morphine and the agent used for 
weaning off (stopping) morphine addiction.  How does it work? 
 (5 marks) 
b Describe how ethanol is eliminated from the body (drawing a flow diagram 
without an explanatory note is NOT an acceptable answer).  Include in your 
answer the enzymes involved and the rate limiting factor. 






End of Section B 
 
End of Exam Paper 
